1D | 2.8 % |
1W | 4.2 % |
2W | 0.8 % |
1M | 0.0 % |
3M | 4.0 % |
6M | -39.7 % |
9M | -30.5 % |
1Y | -36.5 % |
Alpha
-48.4%
|
Beta
0.53
|
sharpe-R
-0.71
|
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
|
sharpe-R Benchmark
2.12
|
Calculation Frequency | Daily |
Latest Valuation Time | 2024-09-16 06:53:51 |
Launch Date | 2023-01-01 00:00:00 |
First Valuation Date | 2021-01-01 00:00:00 |
Max. DrawDown | -49.92% |
Max. DrawDown Benchmark | -8.41% |
This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.
The assets selection in this portfolio is based on: Macro-Pattern Mix St..Try Our Peformance Checker Tool
Asset | Asset Class | Action | Weight | Entry Price | Current Price | PnL | Entry Date |
---|---|---|---|---|---|---|---|
TVTX Travere Therapeutics, Inc. | Equity | Buy | 9.65% | 40.42% | 2024-09-04 | ||
NVCR NovoCure Limited | Equity | Buy | 7.13% | 2.88% | 2024-09-06 | ||
MYGN Myriad Genetics, Inc. | Equity | Buy | 7.09% | 2.3% | 2024-09-09 | ||
CERS Cerus Corporation | Equity | Sell | -3.9% | 1.9% | 2024-09-05 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
TVTX Travere Therapeutics, Inc. | Buy | 9.65% | 40.42% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 7.13% | 2.88% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.09% | 2.3% | 2024-09-09 |
CERS Cerus Corporation | Sell | -3.9% | 1.9% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
MGNX | Sell All | 5.41% |
ESPR | Sell All | 4.37% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
MGNX MacroGenics, Inc. | Buy | 9.47% | 3.13% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.73% | -4.92% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 9.01% | 27.5% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 6.8% | -4.54% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 6.94% | -2.56% | 2024-09-09 |
CERS Cerus Corporation | Sell | -3.97% | 2.84% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
VREX | Buy All | 2.22% |
LMAT | Buy All | 2.57% |
AVXL | Buy All | 12.76% |
PODD | Sell All | 11.4% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
PODD Insulet Corporation | Buy | 9.63% | 10.8% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 9.28% | 1.42% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.65% | -5.46% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 9.42% | 33.75% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 6.65% | -6.37% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.11% | 0.26% | 2024-09-09 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.69% | 3.03% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.24% | 14.88% | 2024-08-29 |
VREX Varex Imaging Corporation | Sell | -3.95% | 2.99% | 2024-09-05 |
CERS Cerus Corporation | Sell | -3.96% | 2.84% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
STAA | Buy All | 6.89% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
PODD Insulet Corporation | Buy | 9.36% | 7.2% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 9.04% | -1.71% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.54% | -7.1% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 9.48% | 33.96% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 6.56% | -7.98% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.17% | 0.63% | 2024-09-09 |
STAA STAAR Surgical Company | Sell | -3.6% | 7.17% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.71% | 2.83% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.35% | 12.41% | 2024-08-29 |
VREX Varex Imaging Corporation | Sell | -3.58% | 12.56% | 2024-09-05 |
CERS Cerus Corporation | Sell | -3.92% | 4.27% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
BGNE | Buy All | -0.8% |
PACB | Buy All | -22.96% |
SGMO | Buy All | -22.22% |
ALDX | Sell All | -6.49% |
AADI | Sell All | 3.43% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
AADI Aadi Bioscience, Inc. | Buy | 6.65% | 4.57% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.33% | 5.05% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 8.66% | -7.41% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.43% | -9.84% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 8.23% | 14.37% | 2024-09-04 |
ALDX Aldeyra Therapeutics, Inc. | Buy | 7.42% | -3.01% | 2024-09-05 |
NVCR NovoCure Limited | Buy | 6.78% | -6.48% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.25% | 0% | 2024-09-09 |
STAA STAAR Surgical Company | Sell | -3.79% | 3.86% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.84% | 1.1% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.4% | 12.41% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -4.55% | -17.04% | 2024-08-29 |
BGNE BeiGene, Ltd. | Sell | -3.28% | 0.24% | 2024-09-02 |
VREX Varex Imaging Corporation | Sell | -4.11% | 1.28% | 2024-09-05 |
CERS Cerus Corporation | Sell | -3.99% | 4.27% | 2024-09-05 |
SGMO Sangamo Therapeutics, Inc. | Sell | -3.04% | 0% | 2024-09-09 |
Asset | Action | Perf % |
---|---|---|
CDMO | Buy All | 16.54% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
AADI Aadi Bioscience, Inc. | Buy | 6.51% | 2.86% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.35% | 5.72% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 8.96% | -3.7% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.75% | -6.01% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 7.41% | 3.44% | 2024-09-04 |
ALDX Aldeyra Therapeutics, Inc. | Buy | 7.61% | 0% | 2024-09-05 |
NVCR NovoCure Limited | Buy | 7.22% | 0% | 2024-09-06 |
CDMO Avid Bioservices, Inc. | Sell | -3.34% | 14.93% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.79% | 3.61% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.83% | 1.07% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.66% | 5.44% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -4.01% | -3.7% | 2024-08-29 |
BGNE BeiGene, Ltd. | Sell | -3.26% | 0.1% | 2024-09-02 |
VREX Varex Imaging Corporation | Sell | -4.24% | -2.31% | 2024-09-05 |
CERS Cerus Corporation | Sell | -4.09% | 1.42% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
CARA | Sell All | -6.41% |
AGEN | Sell All | -8.59% |